Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Direct immunochemiluminescent assay for proBNP and total BNP in human plasma proBNP and total BNP levels in normal and heart failure.

Nishikimi T, Okamoto H, Nakamura M, Ogawa N, Horii K, Nagata K, Nakagawa Y, Kinoshita H, Yamada C, Nakao K, Minami T, Kuwabara Y, Kuwahara K, Masuda I, Kangawa K, Minamino N, Nakao K.

PLoS One. 2013;8(1):e53233. doi: 10.1371/journal.pone.0053233. Epub 2013 Jan 24.

3.

Immunoradiometric assay for the N-terminal fragment of proatrial natriuretic peptide in human plasma.

Numata Y, Dohi K, Furukawa A, Kikuoka S, Asada H, Fukunaga T, Taniguchi Y, Sasakura K, Tsuji T, Inouye K, Yoshimura M, Itoh H, Mukoyama M, Yasue H, Nakao K.

Clin Chem. 1998 May;44(5):1008-13.

4.

High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure.

Bruins S, Fokkema MR, Römer JW, Dejongste MJ, van der Dijs FP, van den Ouweland JM, Muskiet FA.

Clin Chem. 2004 Nov;50(11):2052-8. Epub 2004 Sep 2.

5.

The brain natriuretic peptide (BNP) precursor is the major immunoreactive form of BNP in patients with heart failure.

Seferian KR, Tamm NN, Semenov AG, Mukharyamova KS, Tolstaya AA, Koshkina EV, Kara AN, Krasnoselsky MI, Apple FS, Esakova TV, Filatov VL, Katrukha AG.

Clin Chem. 2007 May;53(5):866-73. Epub 2007 Mar 23.

6.

Diversity of molecular forms of plasma brain natriuretic peptide in heart failure--different proBNP-108 to BNP-32 ratios in atrial and ventricular overload.

Nishikimi T, Minamino N, Ikeda M, Takeda Y, Tadokoro K, Shibasaki I, Fukuda H, Horiuchi Y, Oikawa S, Ieiri T, Matsubara M, Ishimitsu T.

Heart. 2010 Mar;96(6):432-9. doi: 10.1136/hrt.2009.178392. Epub 2009 Dec 4.

PMID:
19966110
7.

Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population.

Lam CS, Burnett JC Jr, Costello-Boerrigter L, Rodeheffer RJ, Redfield MM.

J Am Coll Cardiol. 2007 Mar 20;49(11):1193-202. Epub 2007 Mar 6.

8.

[Amino-terminal pro-brain natriuretic peptide and brain natriuretic peptide measurements under various detection conditions in patients with chronic heart failure].

Wang WJ, Zhang XM, Wang Q, Wen DM, Ouyang NL, Cui YL, Li F.

Zhonghua Xin Xue Guan Bing Za Zhi. 2011 Aug;39(8):695-9. Chinese.

PMID:
22169413
9.

Radioimmunoassay for N-terminal probrain natriuretic peptide in human plasma.

Schulz H, Langvik TA, Lund Sagen E, Smith J, Ahmadi N, Hall C.

Scand J Clin Lab Invest. 2001 Feb;61(1):33-42.

PMID:
11300609
10.

Comparison of brain natriuretic peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure.

Emdin M, Passino C, Prontera C, Fontana M, Poletti R, Gabutti A, Mammini C, Giannoni A, Zyw L, Zucchelli G, Clerico A.

Clin Chem. 2007 Jul;53(7):1289-97. Epub 2007 May 10.

11.

Comparative value of BNP and NT-proBNP in diagnosis of heart failure.

Fonseca C, Sarmento PM, Minez A, Gonçalves E, Covas R, Dias AR, Pina MJ, Ceia F.

Rev Port Cardiol. 2004 Jul-Aug;23(7-8):979-91. English, Portuguese.

12.
14.

Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment.

Hunt PJ, Richards AM, Nicholls MG, Yandle TG, Doughty RN, Espiner EA.

Clin Endocrinol (Oxf). 1997 Sep;47(3):287-96.

PMID:
9373449
15.

[Non-radioimmunometric NT-ProBNP and BNP assays: impact of diluent, age, gender, BMI].

Alibay Y, Schmitt C, Beauchet A, Dubourg O, Alexandre JA, Boileau C, Jondeau G, Puy H.

Ann Biol Clin (Paris). 2005 Jan-Feb;63(1):43-9. French.

PMID:
15689311
16.

Plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in assessment of acute dyspnea.

Alibay Y, Beauchet A, El Mahmoud R, Schmitt C, Brun-Ney D, Benoit MO, Dubourg O, Boileau C, Jondeau G, Puy H.

Biomed Pharmacother. 2005 Jan-Feb;59(1-2):20-4. Epub 2005 Jan 20.

PMID:
15740931
17.

Reference intervals and decision limits for B-type natriuretic peptide (BNP) and its precursor (Nt-proBNP) in the elderly.

Alehagen U, Goetze JP, Dahlström U.

Clin Chim Acta. 2007 Jul;382(1-2):8-14. Epub 2007 Mar 14.

PMID:
17433809
18.

The effect of glycosylation on plasma N-terminal proBNP-76 levels in patients with heart or renal failure.

Nishikimi T, Ikeda M, Takeda Y, Ishimitsu T, Shibasaki I, Fukuda H, Kinoshita H, Nakagawa Y, Kuwahara K, Nakao K.

Heart. 2012 Jan;98(2):152-61. doi: 10.1136/heartjnl-2011-300102. Epub 2011 Jun 30.

PMID:
21719557
19.

Midregional pro-A-type natriuretic peptide measurements for diagnosis of acute destabilized heart failure in short-of-breath patients: comparison with B-type natriuretic peptide (BNP) and amino-terminal proBNP.

Gegenhuber A, Struck J, Poelz W, Pacher R, Morgenthaler NG, Bergmann A, Haltmayer M, Mueller T.

Clin Chem. 2006 May;52(5):827-31. Epub 2006 Mar 16.

20.

Head-to-head comparison of BNP and IL-6 as markers of clinical and experimental heart failure: Superiority of BNP.

Birner CM, Ulucan C, Fredersdorf S, Rihm M, Löwel H, Stritzke J, Schunkert H, Hengstenberg C, Holmer S, Riegger G, Luchner A.

Cytokine. 2007 Nov;40(2):89-97. Epub 2007 Oct 24.

PMID:
17920926
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk